BCL3 and neoplasm: Previously, our published data demonstrated that miR-627-5p is a tumor suppressor for HCC, and BCL3 is the downstream target of miR-627-5p in HCC, and miR-627-5p suppresses HCC progression by targeting BCL3/CCND1 signaling pathway 21, 22.